Impact of OSA treatment success on changes in hypertension and obesity: A retrospective cohort study

Akash Shanmugam1, Zachary O Binney2, Courtney B Voyles3

  • 1Emory College of Arts & Sciences, Atlanta, GA, USA; Oxford College of Emory University, Oxford, GA, USA.

Sleep Medicine
|November 23, 2022
PubMed

Insights

Successful treatment for pediatric obstructive sleep apnea (OSA) improved blood pressure in hypertensive children but did not affect BMI in obese children. Continuous positive airway pressure (CPAP) showed greater blood pressure improvements than surgery.

Area of Science:

  • Pediatric Otolaryngology
  • Cardiology
  • Sleep Medicine

Background:

  • Pediatric obstructive sleep apnea (OSA) is linked to chronic cardiometabolic conditions like obesity and cardiovascular disease.
  • Effective management of pediatric OSA is crucial for mitigating these long-term health risks.

Purpose of the Study:

  • To evaluate the impact of successful continuous positive airway pressure (CPAP) and surgical treatments for pediatric OSA on cardiometabolic outcomes.
  • To compare the effectiveness of CPAP versus surgery in improving systolic blood pressure (SBP) and body mass index (BMI) in children with OSA.

Main Methods:

  • Retrospective review of 414 pediatric patients (≤18 years) diagnosed with OSA between 2015-2019.
  • Collected data included SBP, BMI, apnea/hypopnea index (AHI), and CPAP compliance.
  • Linear mixed-effects models analyzed the relationship between cardiometabolic measures and OSA treatment success.

Main Results:

  • Successful OSA management positively impacted SBP in hypertensive patients but showed no significant effect on BMI in obese patients.
  • CPAP treatment success led to a greater improvement in SBP z-score percentile compared to surgical treatment success.
  • No significant differences in clinical measures were observed for obese patients across any treatment cohort.

Conclusions:

  • Successful management of pediatric OSA benefits hypertensive patients by improving SBP.
  • Continuous positive airway pressure (CPAP) offers superior improvements in SBP for hypertensive children compared to surgical interventions.
  • Current treatment strategies may not significantly alter BMI in obese pediatric patients with OSA.
Abstract

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
208
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
37
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
28
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
43
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
25
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
47